Collaborations

Multiple Myeloma Research Consortium names MDS Pharma Services preferred CRO

Published in Cancer Weekly, May 8th, 2006

The Multiple Myeloma Research Consortium (MMRC) announced that it has selected MDS Pharma Services to serve as its preferred contract research organization (CRO).

In this role, MDS Pharma Services will manage and execute MMRC preclinical and clinical research efforts, including data management related to the tissue accrual into the state-of-the-art MMRC Tissue Bank. The MMRC will also recommend MDS Pharma Services to industry partners as additional protocols are brought through the consortium.

"MDS Pharma Services offers a full spectrum of advanced scientific and technological expertise to significantly accelerate each step of the drug discovery and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2006-05-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry